Skip to main content

The Global Generic Drugs market is expected to reach $738.56 billion by 2026 growing at a CAGR of 12.6% from 2018 to 2026.

The key vendors mentioned are Cipla, Abbott Laboratories, Novartis International AG, Nichi-Iko Pharmaceutical, Mylan NV, Valeant, Hospira (Pfizer Inc.), Dr. Reddy’s, Sresenius Kabi Ag, Baxter International Inc., Actavis Pharmaceuticals, and Eli Lilly and Company.

Hyderabad, India - October 9, 2019 /MarketersMedia/

These drugs are cheaper and equivalent to branded drugs in dosage, strength, route of administration, quality, performance, and application. Generic drugs are subjected to government regulations in various countries rather than being associated with a particular company. Factors such as the increasing prevalence of chronic diseases, diabetes & cardiovascular diseases, growing healthcare expenditure, high demand for generic medicines, and a large number of patent expired branded drugs are driving the market growth. Though, high competition and the shortage of drugs are hampering the market growth.

Access the complete report at: https://www.syngeneresearch.com/global-generic-drugs-market-analysis-2019-2/

Based on the therapy area, anti-infective drugs are agents that act against infections either by inhibiting the spread of an infectious agent or by destroying the infectious agent. Anti-infective drugs are required to destroy infectious agents that cause several infections in the human body such as tuberculosis, sepsis, and smallpox.

Make an inquiry at: https://www.syngeneresearch.com/global-generic-drugs-market-analysis-2019-2/

Drug Deliveries Covered:
• Dermal/Topical
• Inhalers
• Injectables
• Oral
• Parenteral
• Other Drug Deliveries

Brands Covered:
• Pure Generic Drugs
• Branded Generic Drugs

Therapy Areas Covered:
• Dermatology
• Diabetes
• Respiratory Products
• Rheumatology
• Oncology
• Genitourinary/Hormonal
• Gastrointestinal Disorders
• Pain Management

Distribution Channels Covered:
• Retail Pharmacies
• Drug Stores
• Hospitals
• Private Clinics
• Online Pharmacies

Therapeutic Drugs Covered:
• Cardiovascular Products
• Anti-Infective Drugs
• Anti-Arthritis Drugs
• Central Nervous System Drugs
• Anti-Cancer Drug
• Antibiotics

Categories Covered:
• Bio-Similar
• Small Molecule Generics
• Super Generics
• Simple Generics

Regions Covered:
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Learn more about Syngeneresearch here: https://www.syngeneresearch.com/about-syngene-research/

Key Questions Answered in this Report:
• How this market evolved since the year 2016
• Market size estimations, forecasts and CAGR for all the segments presented in the scope
• Key Market Developments and financials of the key players
• Opportunity Analysis for the new entrants
• SWOT Analysis of the key players
• Fastest growing markets analysed during the forecast period

Contact Info:
Name: Sadhana Shukla
Email: Send Email
Organization: Syngene Market Research Reports
Website: https://www.syngeneresearch.com/

Source URL: https://marketersmedia.com/the-global-generic-drugs-market-is-expected-to-reach-73856-billion-by-2026-growing-at-a-cagr-of-126-from-2018-to-2026/88926741

Source: MarketersMedia

Release ID: 88926741

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.